The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.

The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for ...

The FDA has approved Widaplik, a triple-drug combination, for the treatment of hypertension in adults.

The combination will be available in several doses and is also approved as a first-line option for patients with hypertension ...